Innova Captab Ltd. benchmarking: Perfomance to industry peers

Financial

	Innova Captab	Orchid Pharma	Guj. Themis Biosyn
Operational Metrics
Financials
5 yr Average ROE	20.73 %	0.86 %	34.65 %
5yr average Equity Multiplier	2.34	1.61	1.29
5yr Average Asset Turnover Ratio	1.03	0.5	0.74
5yr Avg Net Profit Margin	8.55 %	0.56 %	35.51 %
Price to Book	4.21	3.32	15.74
P/E	34.57	80.96	86.2
5yr Avg Cash Conversion Cycle	31.3 Days	52.03 Days	-112.39 Days
Inventory Days	52.34 Days	112.47 Days	22.82 Days
Days Receivable	89.43 Days	86.58 Days	70.51 Days
Days Payable	105.42 Days	159.29 Days	130.88 Days
5yr Average Interest Coverage Ratio	22.73	3.01	216.76
5yr Avg ROCE	21.99 %	3.08 %	45.66 %
5yr Avg Operating Profit Margin	13.36 %	11.84 %	47.34 %
5 yr average Debt to Equity	0.55	0.37	0.03
5yr CAGR Net Profit	30.09 %	n/a	10.07 %
5yr Average Return on Assets	8.63 %	1.2 %	26.69 %
Shareholdings
Promoter Holding	50.9 %	69.84 %	70.86 %
Share Pledged by Promoters	0.0	0.0	3.3 %
Change in Promoter Holding (3 Yrs)	0.0	-20.12 %	-4.13 %
Change in Mutual Fund Holding (3 Yrs)	7.29 %	15.59 %	1.14 %

	Innova Captab	Orchid Pharma	Guj. Themis Biosyn
Product Wise Break-Up	Product Wise Break-Up Drugs and pharmaceutical products 100.0 Sterile 0 Oral Formulations 0 0	Product Wise Break-Up 0 Drugs and pharmaceutical products 0 Oral Formulations 72.44 Sterile 27.56	Product Wise Break-Up Pharmaceutical 100.0 Drugs and pharmaceutical products 0 Oral Formulations 0 Sterile 0
Segment Break-Up	Segment Break-Up CDMO 69.87 Branded Generics 30.13 Sharon Bio Medicine 0	-	-
Location Wise Break-Up	Location Wise Break-Up India 70.0 Others 30.0	Location Wise Break-Up India 19.9 Others 80.1	-